ES
AGN.PRA

Equitec Specialists’s Allergan plc AGN.PRA Stock Holding History

Equitec Specialists’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100,404
Closed -$58.9M – 129
2017
Q4 		$58.9M Buy
100,404
+81,493
+431% +$52.6M 11.26% 2
2017
Q3 		$14M Buy
18,911
+16,177
+592% +$13.4M 2.15% 12
2017
Q2 		$2.37M Buy
2,734
+1,005
+58% +$842K 0.37% 28
2017
Q1 		$1.47M Buy
1,729
+1,267
+274% +$1.05M 0.32% 27
2016
Q4 		$352K Sell
462
-5,213
-92% -$3.94M 0.08% 59
2016
Q3 		$4.66M Buy
5,675
+2,564
+82% +$2.22M 1.35% 21
2016
Q2 		$2.59M Buy
3,111
+513
+20% +$428K 0.49% 21
2016
Q1 		$2.39M Buy
2,598
+2,221
+589% +$2.12M 0.58% 26
2015
Q4 		$388K Buy
377
+30
+9% +$30.1K 0.14% 52
2015
Q3 		$327K Sell
347
-527
-60% -$550K 0.14% 56
2015
Q2 		$914K Buy
+874
New +$915K 0.24% 43

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return

Equitec Specialists's AGN.PRA Position: Q1 2018 in Review

Equitec Specialists sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 100,404 shares — an estimated $58.9M sold.

Equitec Specialists first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $58.9M in Q4 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Equitec Specialists reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Equitec Specialists sold 100,404 Allergan plc shares in Q1 2018, an estimated $58.9M.
  • Equitec Specialists first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Equitec Specialists's Allergan plc position peaked at $58.9M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Equitec Specialists's 13F filing for Q1 2018, filed 23 May 2018.